Skip to search formSkip to main contentSkip to account menu

bone and joint infections

Known as: bones infections joints, bone joint infections, bone joint infection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Modeling Early Stages of Bone and Joint Infections Dynamics in Humans: A Multi-Agent, Multi-System Based Model
Diagnosis and management of bone and joint infections (BJI) is a challenging task. The high intra and inter patient’s variability… 
2019
2019
Comparison of Neutropenia Associated with Ceftaroline or Ceftriaxone in Patients Receiving at Least 7 Days of Therapy for Severe Infections
Ceftarolinefosamil is a cephalosporin with broad clinical utility; however, limited data suggest that prolonged ceftaroline… 
2019
2019
[Kingella kingae bone and joint infections].
We report six cases of children with probable or confirmed Kingella kingae bone and joint infections (BJI) and discuss the role… 
2018
2018
EPIDEMIOLOGY OF 17 527 BONE AND JOINT INFECTIONS ADDRESSED IN REFERRAL CENTRES IN FRANCE BETWEEN 2012 AND 2016
Aim Bone and joint infections (BJI) are associated with a heavy morbidity and high health costs. Comorbidities, device associated… 
2015
2015
[Descriptive study of bone and joint infections in children in times of community-acquired methicillin- resistant Staphylococcus aureus (CA-MRSA)].
BACKGROUND Bone and joint infections (BJI) are relatively common in children, and community -acquired methicillin resistant… 
2013
2013
Clinical, microbial efficacy and tolerability of Elores, a novel antibiotic adjuvant entity in ESBL producing pathogens: Prospective randomized controlled clinical trial
2013
2013
In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams
In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams 
2012
2012
Genetic Analysis of Glycopeptide-Resistant Staphylococcus epidermidis Strains from Bone and Joint Infections
ABSTRACT Glycopeptide-resistant Staphylococcus epidermidis (GRSE) strains are of increasing concern in bone and joint infections… 
2008
2008
LINEZOLID (LZD) FOR THE TREATMENT OF BONE AND JOINT INFECTIONS (BJI): EFFICACY AND TOLERANCE IN 68 CASES
Purpose of the study: Because of its specific properties, linezolid (LZD) is an alternative to glycopeptides for the treatment of… 
1994
1994
Treatment of bone and joint infections utilizing a third-generation cephalosporin with an outpatient drug delivery device. HIAT Study Group.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)